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Abstract
In healthy people and patients with hypertension, blood pressure varies between clinic visits every several days,  
a week, or a month apart. Although long thought to be an artifact, recent data suggest that visit-to-visit variability of 
blood pressure is reproducible and has independent association with cardiovascular outcomes and mortality. There 
currently is no consensus on how to define blood pressure variability best. The most common metric used is standard 
deviation of mean blood pressure, variation independent of the mean and average real variability. Blood pressure 
variability is higher in female, older age and patients with hypertension, with cardiovascular diseases, with diabetes 
mellitus and chronic kidney disease. Therefore, we are not sure if higher blood pressure variability is the only marker 
of arterial stiffness and consequence of end organ damage or prognostic indicator of cardiovascular events. We also 
do not know whether reducing blood pressure variability would reduce the risk of cardiovascular outcomes. However, 
the number of studies on blood pressure variability is growing exponentially and perhaps in the near future, high 
blood pressure variability will also be the goal of hypertension therapy.
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A great number of publications have long showed 
a significant association between high blood pressure 
and increased cardiovascular risk. The relationship 
between the variability in blood pressure and car-
diovascular disease is much less known, and even 
objectionable. We can distinguish pressure variability 
in short periods of time (the “beat-to beat” variabi-
lity), pressure variability between day and night and 
finally the pressure variability that occurs at longer 
intervals. The influence of absence of the physiolog-
ical pressure drop in hours of sleep on the increase 
of risk of cardiovascular disease is well known [1]. 
Pressure variability in a very short periods of time is 
also the subject of a number of scientific reports and 
their discussion is beyond the scope of the current 
work. Variability in long periods of time can be 
detected through repeated every day, once a week, 
once a month or once every six months pressure 
measurements conducted by the doctor, the patient, 
or more often through repeated automatic measure-
ment (ABPM). It has long been stated that blood 
pressure is usually slightly but significantly higher in 
winter and lower in summer [2]. Regardless of the in-
fluence of the outside temperature, a periodic varia - 
tion in pressure between the pressure measurements 
over long periods of time is becoming a subject of 
rapidly growing number of publications. Initially 
it was thought that this variation is random and 
clinically not relevant. Munter et al. were the first 
to show that variability in long periods of time or 
variability between medical visits (visiting-to-visit 
variability) is repeatable [3]. Cited authors observed 
772 patients with hypertension for almost 3 years 
and made 14 blood pressure measurements in each 
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al. studied a group of patients with hypertension in 
whom the 24-hour mean blood pressure was 159 ± 
5.7 mm Hg and a group of people with normal pres-
sure of an average of 112.9 ± 2.1 mm Hg [5]. They 
demonstrated that changes in blood pressure were 
faster in patients with hypertension and were 6.50 ± 
0.40 mm Hg/s, and in healthy individuals they were 
4.80 ± 0.30 mm Hg/s (p < 0.05).
Zakopoulos et al. showed a significant correlation 
between the variability of blood pressure and the 
carotid intima-media thickness independent of mean 
pressure values and other confounders [9]. Central 
and Eastern Europe had BP-CARE examination an-
alyzing blood pressure variability depending on the 
age of respondents, some coronary risk factors and 
experienced cardiovascular diseases [10]. In the study 
involving more than 6,000 patients with hyperten-
sion, the standard deviation and the coefficient of 
variation of the three blood pressure measurements 
were calculated. Patients with the highest coefficient 
of variation, as compared to patients with the lowest 
rate, were characterized by significantly higher levels 
of cholesterol and blood glucose levels, a higher in-
cidence of resistant hypertension and more frequent 
history of cardiovascular disease [10]. Australian re-
searchers calculated the variation of systolic blood 
pressure in 5,880 patients with hypertension based 
on an average of 8 measurements of pressure during 
4 years [11]. Ten percent of patients with the highest 
degree of pressure variability with respect to 10% of 
the respondents with the lowest pressure variability 
were characterized by a 2.18 times greater risk of car-
diovascular complications, 2.78 times greater risk of 
stroke, 4.11 times greater tendency to myocardial in-
farction and 4.79 times more frequent occurrence of 
failure of the heart. This increased risk remained sta-
tistically significant after taking into account numer-
ous confounding factors such as gender, age of the 
respondents, the average blood pressure values and 
the way of treatment. The analysis of variability of 
blood pressure in 14,382 patients with renal failure 
was conducted by Gorostidi et al. [12]. The patients 
with only hypertension had the standard deviation 
of 13.6 mm Hg, in patients with hypertension and 
in the first stage of renal failure the value was 16.7 
mm Hg and in the fourth stage of renal failure it was 
17.5 mm Hg, while in the fifth stage the value was 
19.0 mm Hg (p < 0.001 for trend). The standard 
deviation for systolic blood pressure at night was 
even higher and ranged from 17.5 mm Hg (with 
still normal renal function) to 23.8 mm Hg during 
end-stage of renal disease. The relationship between 
blood pressure variability and the degree of renal 
failure was greater for night systolic and weaker for 
of them. Each of these patients had standard devia-
tion of the first seven measurements of systolic blood 
pressure calculated, and the same calculations were 
made for the next seven measurements of systolic 
pressure and the existence of a statistically significant 
correlation between the standard deviation in both 
series of measurements was demonstrated. Patients 
qualified for the group of 20% of patients with the 
highest standard deviation in the first seven pressure 
measurements had a strong probability of recurring 
qualification for this group based on the subsequent 
seven measurements of blood pressure. Similar re-
sults were obtained by the cited authors using other 
measures of dispersion than the standard deviation. 
These data testify to the fact that assessed blood 
pressure variability is reproducible and it is not an ac-
cidental value. So far, no uniform guidelines to reco-
mmend the use of selected, most effective measures 
of variability have been developed, and now the au-
thors of various publications on this subject use more 
than 10 different indicators evaluating the degree of 
variability [4]. The most commonly used measures 
of variability included: the standard deviation of the 
mean systolic or diastolic blood pressure, coefficient 
of variability, the maximum difference between the 
values of blood pressure (maximum blood pressure 
variability), variation independent of the mean [4]. 
Recently, more a frequently used indicator is referred 
to as “average real variability”, as determined by the 
formula:
where Xi is the level of blood pressure readings over 
multiple visits.
Some authors use the first derivative of variation 
in systolic blood pressure measured by ABPM, and 
show that the rate of pressure changes included in 
this method correlates in a better way with athero-
sclerotic changes in the organ [5].
In young patients, the variation in blood pressure 
in 50% of cases can be explained by genetic factors [6]; 
in the elderly, 80% variation in pressure depends on 
environmental factors [4]. Numerous studies have 
shown that variability of blood pressure is greater in 
old age [7], and in women than in men [4,8]. Con-
flicting results include the effects of obesity on blood 
pressure variation degree. Interesting, however, are 
the results of studies evaluating the size of variabili-
ty of blood pressure in patients with cardiovascular 
disease.
Variability of blood pressure is greater in patients 
with hypertension than in healthy people. Mancia et 
N–1
S
I = 1
(Xi+1–Xi) (n–1)
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diastolic blood pressure. According to Tanner et al., 
the high-pressure variation can be partly explained by 
a higher average blood pressure in patients with renal 
failure than in healthy people [13].
The relationship between the incidence of stroke 
and blood pressure variation was demonstrated by 
Shimbo et al. [14]. These authors analyzed blood 
pressure variability in 58,228 women participating in 
the Women’s Health Initiative study. Blood pressure 
values were measured every year for an average peri-
od of 5.4 years. At this time, the examined women 
experienced 997 strokes. The variability of systo-
lic blood pressure (measured by standard deviation) 
was significantly higher (after taking into account 
confounding factors) in patients with stroke. This 
relationship was particularly pronounced in women 
with low blood pressure (below 120 mm Hg).
There is growing evidence that increased blood 
pressure variability is not only a marker of cardio-
vascular changes, but it is also a risk factor for future 
strokes or heart attacks. Already in 2010, Rothwell 
et al. showed high variability of blood pressure be-
tween consecutive medical visits, and strokes that 
followed [15]. They re-analyzed the results of a large 
study (ASCOT-BPLA) including patients with hy-
pertension and an additional cohort of patients with 
a history of transient cerebral ischemia. In this group 
of patients from the ASCOT-BPLA study, treated 
for hypertension, high variability in systolic blood 
pressure was a significant risk factor for stroke or 
cardiac ischemia (HR 3.25, p < 0.0001). The cited 
authors also observed that tested relationships are 
better for variability of pressure measured in the 
traditional way, but also important for the ABPM 
measurements especially in younger people and low-
er values of mean blood pressure. In a cohort group 
of patients with transient cerebral ischemia, in those 
with the highest variability in systolic blood pressure 
(measured by value of standard deviation), another 
stroke occurred six times more frequently than in 
those with the lowest variability of pressure, and this 
relationship was independent of the average blood 
pressure (p < 0,0001). An important risk factor also 
included the highest average arterial blood pressure 
(p < 0.0001). Subsequent studies by other authors 
confirm the observations made by Rothwell et al. In 
2015, a post hoc analysis of the results of the so far 
largest study of treatment of hypertension, namely 
ALLHAT, was conducted by Munter et al. [16]. 
They calculated the standard deviation of seven mea-
surements of blood pressure in hypertensive patients 
without symptoms of cardiovascular disease, and 
then traced their fate to the end of the ALLHAT 
study. The patients experienced 606 strokes, 1,194 
cardiac events, with 921 respondents that developed 
symptoms of heart failure, and 1,948 patients died. 
In a quarter of patients with the highest blood pres-
sure variability in the standard deviation of systolic 
blood pressure was more than 14.4 mm Hg, in ¼ of 
patients with the lowest variation, the standard devia-
tion was less than 6.5 mm Hg. The hazard ratio be-
tween the two groups for cardiac ischemic events was 
1.3 (significant change), the overall mortality rate in 
the group with higher pressure variability was 56% 
higher, there was 46% increase in strokes, and final-
ly 25% more patients were likely to develop heart 
failure (all statistically significant changes). Similar 
results were obtained by Vishram et al., analyzing the 
study of LIFE multicenter data [17]. They assessed 
the standard deviation and the range of variability 
of blood pressure measurements made at 6, 12, 18 
and 24 month of study in patients with hyperten-
sion and left ventricular hypertrophy participating 
in the LIFE study. In a multiple regression model, it 
was demonstrated that both the higher variability of 
systolic and diastolic blood pressure in the next 24 
months of the study is a risk factor for stroke and 
a composite endpoint, which includes occurrence of 
death from cardiovascular causes, non-fatal myocar-
dial infarction and stroke. In patients treated with 
losartan, the standard deviation of systolic blood 
pressure was slightly lower than in patients treated 
with atenolol (10.2 ± 6.0 versus 10.9 ± 6.2 mm Hg). 
Elevated concentration of natriuretic peptide in 
the serum frequently precedes myocardial damage. 
A large group of people (664), which is part of the 
overall Japanese population without prior heart dis-
ease, was studied by Satoh et al. [18]. The studied 
group had the concentration of natriuretic peptide 
defined and blood pressure variability determined 
with standard deviation. Increased blood pressure 
variability was predominant in patients with concen-
tration greater than 125 pg/ml of peptide.
Blood pressure variability in long and very long 
periods of time was studied by Hastie et al., among 
14,522 patients with hypertension [19]. The authors 
showed that increased blood pressure variability mea-
sured by “average real variability” is significantly as-
sociated with increased mortality from all causes and 
mortality associated with cardiovascular causes. In 
addition, the authors showed that the studied varia-
bility is higher in women, the elderly, and patients 
with chronic kidney disease.
Takao et al. observed a group of 629 patients 
with type II diabetes who were first hospitalized in 
1995–1996 and then no symptoms of cardiovascular 
diseases were found in them [20]. By 2012, 66 of 
these patients had a heart attack or stroke. Increased 
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blood pressure variability in the period prior to these 
events proved to be an important predictor of cardio-
vascular complications.
Interesting results were also obtained by Chang et al., 
who followed the incidence of cardiovascular events 
depending on the variability in blood pressure [21]. 
The study included 114,900 patients in the 3rd and 
4th stages of renal failure (GFR between 15 and 59 
mL/min) not on dialysis yet. Within 6 months, they 
determined the size of the variability in systolic blood 
pressure by a coefficient of variance, standard devi-
ation and the average real variability. Over the next 
12 months, 5,114 patients died and 582 had to start 
dialysis. In 1/5 of patients with the highest blood 
pressure variability, deaths were by 22% significantly 
higher than in patients with the 1/5 lowest variability 
of pressure. In contrast, 45% higher incidence of 
the need for dialysis in patients with high variability 
in blood pressure after taking into account many 
additional confounding factors turned out to be sta-
tistically insignificant. Hemorrhagic strokes occurred 
in the observed patients slightly more often than 
ischemic strokes and were almost twice as common 
(by 91%) in patients with high variability of pres-
sure, compared with those with the lowest blood 
pressure variability. The incidence of heart attacks 
and the emergence of heart failure in patients with 
kidney failure after taking into account numerous 
confounding factors proved to be much higher but 
statistically insignificant.
On the other hand, Japanese researchers observed 
a correlation between high blood pressure variabili-
ty with subsequent renal failure. A population of 
almost 50, 000 people aged 40–74 years (mean age 
61.7 years) for a period of three years was examined 
by a group of researchers led by Yano [22]. Exclu-
sion criteria included patients with diabetes or renal 
disease (creatinine clearance less than 60 mL/min 
or proteinuria). In all patients, blood pressure was 
measured periodically and its variability was deter-
mined using standard deviation and an “average real 
variability” of blood pressure. In subsequent periods, 
renal failure developed in 6.3% of patients. After 
taking into account many confounding factors such 
as mean arterial pressure, use of antihypertensive 
drugs and metabolic factors, high variability of blood 
pressure has proved to be an important risk factor 
for kidney failure. In a relatively small number of 
patients with peritoneal dialysis, Yokota et al. ob-
served an inverse relationship between blood pressure 
variability and the amount of residual diuresis [23]. 
Pressure variability assessed on the basis of 12 consec-
utive pressure measurements and determined by the 
average real variability highly negatively and signifi-
cantly statistically correlated with gradually decreas-
ing amount of daily urine.
The impact of blood pressure variability on car-
diovascular complications has become a subject of 
2 meta-analyses. A meta-analysis of Stergiou et al. from 
2014, including 22 publications on the home pres-
sure measurements, demonstrated that blood pres-
sure variability based on these measurements is an 
important cardiovascular risk factor independent of 
mean pressure [24]. The authors point out, however, 
that no optimal frequency of pressure measurements 
in the patient’s home has been developed so far, 
neither was determined the most useful indicator 
of pressure variability, and yet there is no threshold 
above which the pressure variability is excessive. In 
another meta-analysis, also from 2014, Diaz et al. 
[25] relied on 37 controlled studies that meet the 
following conditions: blood pressure variability cal-
culated from at least 3 measurements of blood pres-
sure in adults followed by a prospective observation 
regarding the occurrence of myocardial infarction, 
brain stroke, or death, and taking into account nu-
merous confounding factors. The authors of that 
study observed that any increase in the standard 
deviation of a 5 mm Hg was associated with a 27% 
increase in cardiac ischemic events, 17% increase of 
strokes and a 22% increase of total mortality. These 
changes are statistically significant but they are slight 
and their reliability is limited by the small number of 
analyzed publications. It should be emphasized that 
risk factor of cardiovascular events is only slightly 
stronger in non-dipping patients with hypertension 
than the risk factors associated with variability in 
pressure over longer periods of time [26].
On the other hand, Boggia et al. emphasize that 
although some measures of variability in blood pres-
sure may indicate an increased cardiovascular risk 
and all-cause mortality, most important values in-
clude the average pressure and antihypertensive the-
rapy [27].
The literature includes only a few publications 
that have attempted to explain the increased long-
term blood pressure variability. In many patients 
with essential hypertension, the increased activity of 
the sympathetic nervous system is indicated. Coul-
son [28] decided to check the hypothesis that in-
creased catecholamine excretion in the urine (due to 
increased activity of the sympathetic nervous system) 
correlates with increased blood pressure variability. In 
patients with essential hypertension, aged from 23 to 
71, he studied the variability of systolic and diastolic 
blood pressure measured by ABPM and excretion of 
normetadrenaline and metadrenaline. In this study, 
the author has demonstrated a statistically significant 
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correlation between the variability in blood pressure 
measured by the value of standard deviation and ratio 
of the standard deviation to the average pressure, and 
the daily excretion of normetadrenaline (r = 0.493, 
p < 0.02). It should be noted that the author did not 
observe a significant correlation between mean blood 
pressure and catecholamine excretion in the urine. In 
contrast, this relationship has been demonstrated be-
tween subjects’ age and the blood pressure variability 
and the excretion of normetadrenaline.
According to Diaz et al., huge variability in blood 
pressure may increase the incidence of cardiovascular 
complications through adverse effects on the vascu-
lar endothelium [29]. The authors studied a group 
of 72 people with blood pressure lower than 160/ 
/100 mm Hg, not smoking and with normal choles-
terol, glucose and creatinine values, whose pressure 
variability was calculated based on three separate vis-
its to doctors and based on ABPM study. All patients 
were subjected to ultrasound tests assessing the fore-
arm brachial artery diameter in response to increased 
flow (FMD) and nitroglycerin administration. The 
authors showed a significant negative correlation be-
tween blood pressure variability and expansion of 
the brachial artery and a positive correlation after 
administration of nitroglycerin. Impaired endothelial 
function caused by increased blood pressure variabili-
ty may, according to Diaz et al., be largely responsible 
for the increased number of cardiovascular complica-
tions. Significant endothelial dysfunction in patients 
with high long-term pressure variability was also ob-
served by Chinese researchers [30]. A group of 174 
patients with hypertension were subject to calcula-
tions of pressure variation within 12 months of peri-
odic measurements and the ultrasound demonstrated 
an impaired expansion of the brachial artery (FMD 
study) in patients with increased pressure variability.
Long-term blood pressure variability is currently 
the subject of an increasing number of works that 
will probably soon assess more thoroughly its im-
portance in the pathogenesis of complications of 
hypertension. There are also studies on such treat-
ment of hypertension, which will help to reduce this 
variability. However, we should already be aware of 
the possible dangers that may be connected with ex-
cessive pressure variability in the long-term.
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